Hereditary Breast and Ovarian Cancer Syndrome - 24 Studies Found
Active, not recruiting |
: Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy :
|
Recruiting |
: A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer :
: 2014-07-29 : Drug: LY2606368 105 mg/m2 IV once every 14 days of a 28 day cycle |
Completed |
: Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) :
: 2009-01-26 : Behavioral: Questionnaire 1 - 2 questionnaires, lasting 10-15 minutes. |
Active, not recruiting |
: Genetic Counseling for Breast Cancer Survivors (GC for BC) : Breast Cancer : 2015-05-18 :
|